Methods
After obtaining Institutional Ethics Committee approval and written informed consent, 60 patients age between 18 and 65 years, ASA grade I or II, body mass index (BMI) between 18 and 30 kg/m 2 , for various elective surgical procedures with anticipated duration not exceeding 2 h were enrolled for this prospective, randomised, double-blinded study. Patients with presence of any significant acute or chronic lung disease, inadequate cervical mobility/cervical malformation, with known/predicted difficult airway/reduced mouth opening/disease of oral cavity, full stomach/ increased risk of aspiration (GERD, hiatus hernia, diabetes mellitus), pregnancy, surgery of the head and neck procedures not performed in supine position and laparoscopic surgeries were excluded from the study.
After computer-generated randomisation, patients were assigned in either Group I or E in which airway management was done with i-gel or with cuffed ETT. I-gel size 3 for 30-60 kg; 4 for 50-90 kg and a size 5 was used for >90 kg weight. ETT size 8.5 mm ID for male and 7.5 for female participants was used. The patients were pre-medicated with intravenous fentanyl 2 µg kg -1 , and anaesthesia was induced with propofol 1.5-2 mg kg -1 and muscle relaxation achieved with rocuronium 0.6 mg kg -1 and confirmed using a trainof-four stimulation count (TOF=0). The cuff of the ETT was inflated to a pressure of 25 cm H₂O using a handheld aneroid pressure gauge and placement confirmed by capnography and by chest auscultation.
Insertion time was recorded as time from insertion of i-gel into the mouth or insertion of laryngoscope blade into the mouth to appearance of the first capnographic square waveform. Each 'attempt' would be defined as re-insertion of the airway device into the mouth and the respective times would be T1, T2 and T3. Effective airway time would have been calculated by adding T1, T2 and T3. We defined 'insertion failure' of the device as one comprising more than three unsuccessful attempts in which case the airway would have been secured at the discretion of the senior anaesthesiologist supervising the case. The ease of insertion of the airway device was subjectively assessed on a 5-point scale (1=easy, 2=not so easy, 3=difficult, 4=very difficult, 5=impossible). In Group I, an appropriate-sized nasogastric tube (size 14 Fr for size 5 i-gel and 12 Fr for sizes 3 and 4 i-gel) was inserted through the gastric drain channel after lubrication. Ease of insertion of the gastric tube was assessed on a 3-point scale (1=easy, 2=difficult, 3=impossible). Confirmation of proper placement of the gastric catheter was by detection of injected air by auscultation over the epigastrium and by aspiration of gastric contents. In both the groups, heart rate (HR), non-invasive blood pressure (NIBP), oxygen saturation (SpO 2 ) and end tidal carbon dioxide (EtCO 2 ) were recorded before induction (baseline), before device insertion (T0), every minute  for the first 5 min after insertion of the airway device (T1,  T2, T3, T4, T5) and henceforth, every 5 min for the entire duration of the surgery.
Airway leak tests were then performed in Group I. The fresh gas flow was adjusted to 3 L min -1 , and the adjustable pressure limiting valve of the circle system was completely closed. Airway pressures were not allowed to exceed 40 cm H₂O.
Test 1 (Auscultation):
Measured the minimal airway pressure at which an audible gas leak occurred by using a stethoscope placed just lateral to thyroid cartilage.
Test 2 (Manometer stability):
Observation of the aneroid manometer dial as the pressure from the breathing system increased and noted the airway pressure at which the dial reached stability (i.e. the airway pressure at which leak is in equilibrium with fresh gas flow).
Anaesthesia was maintained with O₂ and N 2 O in isoflurane (1%-1.5%). Once a clear airway was established, the lungs were ventilated at three different pressures (15, 20, 25 cm H₂O) using PCV at a rate of 10 breaths min -1 and an I:E ratio of 1:2 with no PEEP. Inspired tidal volumes (TV) and expired TV were recorded, and the leak volume (LV=ITV -ETV) was calculated. The leak fraction (LF) was calculated as LV divided by ITV (i.e. LF=LV/ITV). Measurements were taken over 10 breaths for each pressure setting.
Gastric insufflation was assessed by auscultation over the patient's epigastric area. PCV was then maintained at the pressure (15, 20, 25 cm H₂O) which was lower than the leak pressure of the device in group I and at 20 cm H₂O in Group E at a rate adapted to maintain EtCO 2 in the range of 30-35 mm Hg. Thirty minutes later, once again, the LF was estimated with pressures of 15, 20 and 25 cm H₂O and measurements were taken over 10 breaths for each pressure setting.
At the end of the surgery, any blood staining on the laryngoscope, the tracheal tube, or i-gel was documented. Complications during insertion, maintenance and removal were noted for each patient. Pharyngolaryngeal morbidity was evaluated in the recovery room and 24 h postoperatively.
The primary endpoint of our study was the difference in the LF between the two airway devices under investigation. Secondary outcomes included differences in the LV, airway leak pressures, success of first attempt insertion, number of manipulations after or during insertion, haemodynamic response to device insertion and any complications.
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Statistical analysis
The sample size was calculated to be 30 in each group with an α error of 0.05 and power of 90% considering a difference in the LF of more than 16% to be significant. Quantitative data (LF, LV, airway leak pressures and time of insertion) were analysed using unpaired t test. Qualitative data (ease of insertion, success rate first attempt insertion, number of insertion attempts and any complications) were compared using c 2 test.
Results
The patients' demographic profile including age, sex, height, weight, BMI and ASA physical status were comparable in both the groups ( Table 1 ). The airway examination including interdental distance, thyromental distance, Modified Mallampati classification and neck circumference were comparable in both the groups (Table 1) .
I-gel is easier (easy in 96.67% and not so easy in 3.33% patients) to insert as compared to an ETT (easy in 73.33%, not so easy in 20% and difficult in 6.67% patients) (p=0.0056).
The mean time for insertion of device in group I and E was found to be 10.03±2.01 and 16.67±2.87 seconds (p<0.001).
In both the groups, airway devices were successfully placed in the first attempt. Two patients in Group I required jaw thrust, whereas five patients in Group E required external laryngeal manoeuvres with no trauma/adverse events at insertion. In group I, gastric tube was successfully placed in all the patients. Insertion of the gastric tube was easy in 27 patients (90%) and difficult in three patients (10%).
Between the two groups, HR was comparable at baseline and decreased slightly before device insertion. However, the increase in HR was higher following insertion of ETT in the first three minutes (p<0.001) and then became comparable at T4 and T5 between the two groups ( Table 2 and Figure 1) . Also, the increase in MAP values was higher in Group E in first four minutes after insertion (p<0.001) and became insignificant at the fifth minute after device insertion (Table 2 and Figure 1 ). There were no complications of pharyngolaryngeal morbidity as defined during insertion, maintenance and removal of the device in either group. Blood on removal of device was seen on two i-gel's (6.67%), which could be attributed to slight trauma to the oropharyngeal mucosa occurring (Table 4) .
Discussion
Recently, there has been a trend towards substituting an SAD for a tracheal tube for controlled ventilation in patients with a minimal risk of aspiration.
The i-gel has been studied and shown to have high insertion success rate and low device failures under both spontaneous and controlled ventilation (7, (14) (15) (16) (17) . Various studies have reported a median insertion time for the i-gel ranging from 5 to 15 sec (14, 16, 18) .
The haemodynamic response to insertion of i-gel was significantly less than that for endotracheal intubation (2, 19) and is a reflection of an increase in sympathoadrenal activity due to oropharyngeal and laryngotracheal stimulation (20) . I-gel has a soft gel thermoplastic elastomer cuff and may prevent stress stimulation. All the haemodynamic parameters returned to near-baseline values within 5 min of device insertion in our study. Previous study also concluded that the NIBP, HR, plasma epinephrine, norepinephrine and vasopressin concentrations increased slightly in response to laryngoscopy and intubation, all returning to or below baseline 5 min later (21).
The mean airway seal pressure varies to be 24 to 30 cm H 2 O (14-17, 22) for i-gel using the auscultation method and manometer stabilisation method. Among tests available for assessing sealing pressure, manometer stability test had better interobserver reliability and may be more appropriate (23) , and studies have found no difference between values obtained by manometer stability and auscultation method (22) .
During PCV, the LV is affected by the pressure generated by the airway device against the supraglottic tissues and has been found to be a more efficient and safer mode than volume-controlled ventilation for controlled ventilation with a SAD (9-13).
We found slight decrease in the LV and LF 30 min later in Group I. Probably, the seal with the i-gel did not seem to T1  T2  T3  T4  T5 improve much over time in our study. One of the possible reasons could be re-using of the i-gel in our study. It is found that ventilation with the SAD was adequate at all ventilation pressures and comparable with tracheal tube ventilation (24) . Our study found similar LFs for ETT at different pressures. No significant difference was found between the LFs of the i-gel and the tracheal tube measuring the gas leaks with i-gel and comparing these values with that of the ETT (22) . They suggested that the i-gel can be used as a reasonable alternative to the tracheal tube during PCV with moderate airway pressures. The LFs and LVs at 20 and 25 cm H 2 O PCV were comparable with those found in our study.
Pharyngolaryngeal morbidity findings are similar to those reported with other SADs. The incidence of visible blood with the use of other SADs has been quoted from 12% to 18%, depending upon the type of SAD, the technique of insertion and ease of insertion (25) . Airway management had the strongest influence on the incidence of pharyngolaryngeal morbidity. Literature (4, 5, 26) conclude that use of i-gel has shown clinically fewer postoperative sore throat (6%-12%), dysphagia (4%-17.5%), hoarseness (4%-12%) compared to ETT having sore throat (22%-45%), dysphagia (2%-11%) and dysphonia (4%). The low morbidity rate in our study is of note and could have been due to the high first attempt success rate and the tensile properties of the non-inflatable cuff resulting in a lower pressure being exerted against the pharyngeal structures.
Our study had some limitations. First, it was not a crossover study so we could not limit the influence of interpatient variability during the comparison. Second, we were re-using i-gels due to financial constraints. In addition, we did not assess the sealing pressure after 30 min. It could have perhaps added important information, as reports have emerged that the seal of the i-gel seems to improve over time due to the thermoplastic cuff's warming to body temperature (6, 7) . It was also impossible to blind the airway operator to the device used, hence leading to a potential for bias. We only studied non-obese patients with normal airways, and the results cannot directly be extrapolated to other types of patients. Therefore, we cannot comment on results obtained with obese patients, during difficult airway management or with naïve users, although we speculate that the results found would be similar in these scenarios.
Conclusion
We found that an i-gel is significantly easier and quicker to insert than an endotracheal intubation. Leak fraction of an i-gel as compared to an ETT was similar with PCV at 15 cm H 2 O. At higher pressures there was a small but significant increase in LF when comparing i-gel with an ETT. Hemodynamic response to insertion and pharyngolaryngeal morbidity was significantly less with an i-gel as compared to an ETT. Our study concludes that the i-gel provides a reasonable alternative to the ETT for controlled ventilation in adult patients undergoing routine surgical procedures provided the pressures can be limited to 15-20 cm H 2 O.
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